Tag: Cancer Genome Atlas

EMUC15: Challenges and developments in urological cancers

From diagnosis, systemic treatment to surgical management, experts and specialists in urological cancers assessed current practices and prospects while noting that the steady gains already achieved will hopefully lead to more optimal therapies. “Since 2007 when we had our...

EMUC15: Bladder Cancer Updates on systemic treatments

Updates on systemic treatments for bladder cancer were discussed and examined in the second plenary session of the 7th European Multidisciplinary Meeting on Urological Cancers (EMUC15), with experts noting the small gains in drug therapy and possible prospects. Prof....

EAU15: Robot-assisted radical cystectomy: still not the new standard

Robot-assisted radical cystectomy fails to clinch the title “new standard” as bladder cancer experts yesterday looked into recent data-or the lack thereof-that could support a crucial advantage over the traditional or open surgery approach. “Robot-assisted radical cystectomy (RARC) is...

Molecular profiling in bladder cancer

The Cancer Genome Atlas Project (TCGA) began as a three-year pilot project co-funded by the National Cancer Institute and National Human Genome Research Institute to characterize glioblastoma multiforme, lung and ovarian cancer. The early success led to expanded funding...
ESUR 2014: An interview with Prof. Ellen Zwarthoff

ESUR 2014: An interview with Prof. Ellen Zwarthoff

Ahead of the 22nd ESUR meeting in Glasgow, Prof. Ellen Zwarthoff (Rotterdam, NL), biochemist and winner of this year’s Dominique Chopin Award for significant achievements in urological research, talks on the challenges in urological research and the importance of...